Of course there is something in the works. With an approved product, which looks to form a multi billion dollar franchise over the next while, anybody seriously who thinks this is not under the radar of big pharma is missing the obvious. The only question is, does it go way higher first, or is there a bid on the company. Either way, 2013 is going to be a big UP year for this stock. Any DD indicates this.